Effects of haloperidol and GM1 ganglioside treatment on striatal D2 receptor binding and dopamine turnover. 1998

M A Vital, and J C Flório, and R Frussa-Filho, and R De Lucia, and S Tufik, and J Palermo-Neto
Department of Pharmacology, Federal University of Paraná, Curitiba, PR, Brazil.

Previous studies have shown that whereas exogenous GM1 ganglioside co-administration leads to an increase of haloperidol-induced behavioral supersensitivity, GM1 significantly attenuates the behavioral parameters of dopaminergic supersensitivity when administered after abrupt haloperidol withdrawal. In the present study, the effects of GM1 and haloperidol co-administration (5 mg/kg GM1 i.p. and 1 mg/kg haloperidol i.p., twice daily, for 30 days) as well as the effects of a 3 day treatment with GM1 were investigated in rats withdrawn from haloperidol administration by measuring striatal D2 dopamine receptor binding and dopamine turnover. The results showed that under these two experimental conditions GM1 modified neither the haloperidol-induced striatal D2 dopamine receptor up regulation nor the decrease in dopamine turnover produced by haloperidol withdrawal. These results suggest that the effects of GM1 on behavioral supersensitivity are not related to modifications in dopamine receptor number or affinity and in the synaptic availability of this catecholamine.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D003342 Corpus Striatum Striped GRAY MATTER and WHITE MATTER consisting of the NEOSTRIATUM and paleostriatum (GLOBUS PALLIDUS). It is located in front of and lateral to the THALAMUS in each cerebral hemisphere. The gray substance is made up of the CAUDATE NUCLEUS and the lentiform nucleus (the latter consisting of the GLOBUS PALLIDUS and PUTAMEN). The WHITE MATTER is the INTERNAL CAPSULE. Lenticular Nucleus,Lentiform Nucleus,Lentiform Nuclei,Nucleus Lentiformis,Lentiformis, Nucleus,Nuclei, Lentiform,Nucleus, Lenticular,Nucleus, Lentiform,Striatum, Corpus
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D005677 G(M1) Ganglioside A specific monosialoganglioside that accumulates abnormally within the nervous system due to a deficiency of GM1-b-galactosidase, resulting in GM1 gangliosidosis. GM1 Ganglioside,Monosialosyl Tetraglycosyl Ceramide,GM1a Monosialoganglioside,Ceramide, Monosialosyl Tetraglycosyl,Ganglioside, GM1,Monosialoganglioside, GM1a,Tetraglycosyl Ceramide, Monosialosyl
D006220 Haloperidol A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279) Haldol
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013134 Spiperone A spiro butyrophenone analog similar to HALOPERIDOL and other related compounds. It has been recommended in the treatment of SCHIZOPHRENIA. Spiroperidol,Spiroperone

Related Publications

M A Vital, and J C Flório, and R Frussa-Filho, and R De Lucia, and S Tufik, and J Palermo-Neto
August 1987, Neuroscience letters,
M A Vital, and J C Flório, and R Frussa-Filho, and R De Lucia, and S Tufik, and J Palermo-Neto
September 1990, European journal of pharmacology,
M A Vital, and J C Flório, and R Frussa-Filho, and R De Lucia, and S Tufik, and J Palermo-Neto
January 1987, Psychopharmacology,
M A Vital, and J C Flório, and R Frussa-Filho, and R De Lucia, and S Tufik, and J Palermo-Neto
December 1987, Brain research,
M A Vital, and J C Flório, and R Frussa-Filho, and R De Lucia, and S Tufik, and J Palermo-Neto
July 1992, Brain research. Molecular brain research,
M A Vital, and J C Flório, and R Frussa-Filho, and R De Lucia, and S Tufik, and J Palermo-Neto
December 1997, Pharmacology, biochemistry, and behavior,
M A Vital, and J C Flório, and R Frussa-Filho, and R De Lucia, and S Tufik, and J Palermo-Neto
July 1977, Science (New York, N.Y.),
M A Vital, and J C Flório, and R Frussa-Filho, and R De Lucia, and S Tufik, and J Palermo-Neto
March 1979, Brain research,
M A Vital, and J C Flório, and R Frussa-Filho, and R De Lucia, and S Tufik, and J Palermo-Neto
September 2015, Journal of the neurological sciences,
M A Vital, and J C Flório, and R Frussa-Filho, and R De Lucia, and S Tufik, and J Palermo-Neto
October 2017, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!